EKF Diagnostics (LON:EKF) Share Price Passes Above Two Hundred Day Moving Average – Time to Sell?

EKF Diagnostics Holdings plc (LON:EKF) crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 25.43 and traded as high as GBX 27. EKF Diagnostics shares last traded at GBX 26.80, with a volume of 39,465 shares changing hands.

Analyst Ratings Changes

Separately, Stifel Nicolaus reiterated a “buy” rating and set a GBX 35 price target on shares of EKF Diagnostics in a research report on Wednesday, April 22nd. One research analyst has rated the stock with a Buy rating, According to MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of GBX 35.

EKF Diagnostics Trading Down 3.4%

The firm has a market capitalization of £111.50 million, a price-to-earnings ratio of 55.11 and a beta of 0.52. The firm’s 50 day moving average is GBX 25.83 and its 200 day moving average is GBX 25.44. The company has a quick ratio of 1.77, a current ratio of 4.16 and a debt-to-equity ratio of 2.01.

EKF Diagnostics (LON:EKF) last issued its earnings results on Tuesday, March 24th. The company reported GBX 0.47 earnings per share for the quarter. EKF Diagnostics had a net margin of 4.12% and a return on equity of 3.01%. Equities analysts forecast that EKF Diagnostics Holdings plc will post 2.2987842 earnings per share for the current year.

About EKF Diagnostics

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.